James Theophile Gourzis, Director at PRO PHARMACEUTICALS INC (PRW), bought 2,000 shares at $0.22 ($440) on 2008-09-19, disclosed to the SEC on 2008-09-22.
Open-market purchase of $440 PRW by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.